Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
CCORF Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $26
CCORF analyst Sumant Kulkarni maintains $Annovis Bio(ANVS.US)$ with a buy rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 42.0% and a
Buy Rating on Annovis Bio Amid Progress in PD and AD Drug Development
Annovis Bio, Inc. (NYSE:ANVS) Surges 24%; Retail Investors Who Own 56% Shares Profited Along With Insiders
Maxim Group Maintains Annovis Bio(ANVS.US) With Hold Rating
Maxim Group analyst Jason McCarthy maintains $Annovis Bio(ANVS.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 24.4% and a total average return of -22.1% over
Annovis Bio (ANVS) Receives a Hold From Maxim Group
EF Hutton Maintains Buy on Annovis Bio, Maintains $21 Price Target
Annovis Bio Shares Surge After Q2 Net Loss Narrows
HC Wainwright & Co. Reiterates Buy on Annovis Bio, Maintains $30 Price Target
Annovis Bio Q2 2024 GAAP EPS $(0.44) Misses $(0.35) Estimate, Cash And Cash Equivalents Totaled $4M
Express News | Annovis Bio Inc Q3 Shr View $-0.45 -- LSEG IBES Data
Express News | Annovis Bio Inc- Qtrly Shr Loss $0.44
Annovis Bio 2Q Loss/Shr 44c >ANVS
Buy Rating Affirmed for Annovis Bio Amid Promising Buntanetap Trials and Stable Financials
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
Annovis Bio | 10-Q: Q2 2024 Earnings Report
EF Hutton Initiates Coverage On Annovis Bio With Buy Rating, Announces Price Target of $21
EF Hutton Initiates Annovis Bio(ANVS.US) With Buy Rating, Announces Target Price $21
EF Hutton analyst Jason Kolbert initiates coverage on $Annovis Bio(ANVS.US)$ with a buy rating, and sets the target price at $21.According to TipRanks data, the analyst has a success rate of 32.6%
Maxim Group Keeps Their Hold Rating on Annovis Bio (ANVS)
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Sensei Biotherapeutics (SNSE) and Annovis Bio (ANVS)